News release

Date: 24th February 2015

Fast-growing regulatory affairs service provider ELC Group expands corporate presence in Czech Republic

Major contract wins in China and US fuel latest move into larger premises in Prague

Cambridge, UK, 24th February 2015 –  ELC Group, one of the fastest-growing providers of regulatory affairs services, today announces that it is expanding its office presence in Prague in the Czech Republic due to accelerating company growth. From May, ELC Group will be occupying nearly 2000 square metres of offices at Danube House, located in the prime River City Prague business district.

The move is being fuelled by ELC Group’s rapidly expanding customer base, which includes recent major contract wins in China and the US. The increased office space will accommodate ELC Group’s growing team of project management staff and subject matter experts, with staff numbers based in the Czech capital set to almost double within the next three months.

ELC Group’s corporate strategy has delivered a sustained period of exceptional growth over the past five years, leading to the opening of new and expanded operational offices in Mumbai, Ahmedabad, Singapore and Russia, and the establishment of a new global headquarters in Cambridge, UK. ‘From Concept to Commercialisation’ is one of the new, key partnership areas in which ELC Group is creating its success, offering expert consultancy services from the development stage through to the implementation of clinical trials, completion of product registration, and successful product marketing. In a further extension of its solution portfolio, in 2012 ELC Group also announced the launch of a software subsidiary – Pharma eReport – which is now successfully delivering a complete and proven XEVMPD compliance solution for major global pharmaceutical Marketing Authorisation Holders.

Commenting on the Prague office expansion, ELC Group CEO Marco Rubinstein said: “ELC Group is fast becoming one of the industry’s stand-out success stories. Our unmatched sector experience, strong track record of delivery, and our world-class team of experts mean that our services are more in demand than ever, and we are very proud to be expanding our presence in the Czech Republic, which provided the base for ELC Group’s phenomenal development from the very beginning.”


Note to editors:

If you would be interested in scheduling a briefing with ELC Group, please contact Nicky Denovan at nicky[at]evokedset[dot]com.

Press contacts:
Akhil Jain
ELC Group
ajain [at] elc-group [dot] com
Phone: +420 22 491 00 00

Nicky Denovan
EvokedSet PR
nicky[at] evokedset [dot] com
Phone: +44 (0)118 3282782

About ELC Group:
ELC GROUP is a fully-fledged global regulatory partner, working with major pharmaceutical stakeholders for over a decade.

From Concept to Commercialisation is one of the key partnership areas in which ELC GROUP is creating its fast-growing success. From the development stage through to the implementation of clinical trials, completion of product registration, and successful marketing of the product, ELC GROUP aligns itself as a strategic partner to help pharmaceutical companies achieve their healthcare goals.

ELC GROUP’s worldwide network of professionals spans all major Regulatory Affairs services across the key healthcare vertical markets of Pharmaceuticals, Biotech, Clinical, Consumer Healthcare, Medical Devices, Nutraceuticals and Veterinary. The team ranges from former FDA investigators to individuals with over 30 years of industry experience and broad capabilities, including in the areas of integrated advanced technologies, Regulatory Affairs consulting and commercialisation services.

ELC GROUP works with equal success in partnership with large multi-nationals, small enterprises and start-ups, biotechs, CROs and device manufacturers.

Close This Window